Back to Journals » Biologics: Targets and Therapy » Volume 9
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (514)
- Volume 18, 2024 (18)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 9, 2015
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
Fecher LA, Sharfman WH
Biologics: Targets and Therapy 2015, 9:129-140
Published Date: 6 November 2015
Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
Sangiorgi D, Benucci M, Nappi C, Perrone V, Buda S, Degli Esposti L
Biologics: Targets and Therapy 2015, 9:119-127
Published Date: 6 November 2015
Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
Thomsen SF, Sand FL
Biologics: Targets and Therapy 2015, 9:117-118
Published Date: 6 November 2015
Role of collagenase clostridium histolyticum in Peyronie's disease
Peak TC, Mitchell GC, Yafi FA, Hellstrom WJ
Biologics: Targets and Therapy 2015, 9:107-116
Published Date: 29 September 2015
Clinical utility of ramucirumab in advanced gastric cancer
Chan MMK, Sjoquist KM, Zalcberg JR
Biologics: Targets and Therapy 2015, 9:93-105
Published Date: 22 September 2015
Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease
Preto E, Lima NEA, Simardi L, Fonseca FLA, Fragata Filho AA, Maifrino LBM
Biologics: Targets and Therapy 2015, 9:87-92
Published Date: 23 September 2015
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M
Biologics: Targets and Therapy 2015, 9:75-86
Published Date: 18 September 2015
Giant-cell tumor of bone: treatment options and role of denosumab
Singh AS, Chawla NS, Chawla SP
Biologics: Targets and Therapy 2015, 9:69-74
Published Date: 14 July 2015
Localization and upregulation of survivin in cancer health disparities: a clinical perspective
Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR
Biologics: Targets and Therapy 2015, 9:57-67
Published Date: 9 July 2015
Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib
Reck M, Mellemgaard A
Biologics: Targets and Therapy 2015, 9:47-56
Published Date: 1 July 2015
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C
Biologics: Targets and Therapy 2015, 9:45-46
Published Date: 29 June 2015
Biologic monotherapy in the treatment of rheumatoid arthritis
Detert J, Klaus P
Biologics: Targets and Therapy 2015, 9:35-43
Published Date: 14 May 2015
Role of biologics in intractable urticaria
Cooke A, Bulkhi A, Casale TB
Biologics: Targets and Therapy 2015, 9:25-33
Published Date: 13 April 2015
Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
Bardy-Bouxin N, Matczak E, Devgan G, Woloj M, Shapiro M
Biologics: Targets and Therapy 2015, 9:23-24
Published Date: 19 February 2015
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
Cerquozzi S, Owen C
Biologics: Targets and Therapy 2015, 9:13-22
Published Date: 16 February 2015
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
Benucci M, Li Gobbi F , Meacci F, Manfredi M, Infantino M, Severino M, Testi S, Sarzi-Puttini P, Ricci C, Atzeni F
Biologics: Targets and Therapy 2015, 9:7-12
Published Date: 17 February 2015
Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
Codreanu C, Damjanov N
Biologics: Targets and Therapy 2015, 9:1-6
Published Date: 27 January 2015